NP Life Sciences Health Industry Group Inc. Retained Earnings
NP Life Sciences Health Industry Group Inc. (ACAT) had Retained Earnings of -$348.25 thousand as of 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-04-16
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$348.25K.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$332.89K.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$297.51K.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$344.09K.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-12-31 | -$348.25K 10-K · filed 2024-04-16 |
| 2023-09-30 | -$332.89K 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$297.51K 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$344.09K 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$345.31K 10-K · filed 2024-04-16 |
| 2022-09-30 | -$361.91K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$356.47K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$357.55K 10-Q · filed 2022-05-23 |
| 2021-12-31 | -$326.45K 10-K · filed 2023-04-18 |
| 2021-09-30 | -$358.72K 10-Q · filed 2021-11-22 |
| 2021-06-30 | -$337.76K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$285.02K 10-Q · filed 2021-05-17 |
| 2020-12-31 | -$260.78K 10-K · filed 2022-04-15 |
| 2020-09-30 | -$239.12K 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$213.49K 10-Q · filed 2020-08-14 |
| 2020-03-31 | -$159.83K 10-Q · filed 2020-05-15 |
| 2019-12-31 | -$129.71K 10-K · filed 2021-04-15 |
| 2019-09-30 | -$87.39K 10-Q · filed 2019-11-15 |
| 2018-12-31 | -$20.89K 10-K · filed 2020-03-30 |